INSMED INC Stock-Based Compensation
INSMED INC (INSM) reported Stock-Based Compensation of $87.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- INSMED INC share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $41.25M, a 4.01% decline year-over-year.
- INSMED INC share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $45.75M, a 16.54% increase year-over-year.
- INSMED INC share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $39.04M, a 47.02% increase year-over-year.
- INSMED INC share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $31.43M, a 23.05% increase year-over-year.
- INSMED INC share-based payment arrangement, noncash expense for fiscal 2025 was $152.71M, a 57.70% increase from fiscal 2024.
- INSMED INC share-based payment arrangement, noncash expense for fiscal 2024 was $96.83M, a 29.50% increase from fiscal 2023.
- INSMED INC share-based payment arrangement, noncash expense for fiscal 2023 was $74.78M, a 29.63% increase from fiscal 2022.
- INSMED INC share-based payment arrangement, noncash expense for fiscal 2022 was $57.69M, a 25.35% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $87.01M 10-Q · filed 2026-08-06 | $126.05M derived: sum of 3 quarters · filed 2026-08-06 | $157.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $45.75M 10-Q · filed 2026-05-07 | $84.79M derived: sum of 2 quarters · filed 2026-05-07 | $116.23M derived: sum of 3 quarters · filed 2026-05-07 | $159.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $39.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $70.47M derived: sum of 2 quarters · filed 2026-02-19 | $113.45M derived: sum of 3 quarters · filed 2026-08-06 | $152.71M 10-K · filed 2026-02-19 |
| 2025-09-30 | $31.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $74.41M derived: sum of 2 quarters · filed 2026-08-06 | $113.67M 10-Q · filed 2025-10-30 | $140.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $42.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $82.24M 10-Q · filed 2026-08-06 | $108.79M derived: sum of 3 quarters · filed 2026-08-06 | $134.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $39.26M 10-Q · filed 2026-05-07 | $65.82M derived: sum of 2 quarters · filed 2026-05-07 | $91.36M derived: sum of 3 quarters · filed 2026-05-07 | $114.65M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $26.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $52.10M derived: sum of 2 quarters · filed 2026-02-19 | $75.39M derived: sum of 3 quarters · filed 2026-02-19 | $96.83M 10-K · filed 2026-02-19 |
| 2024-09-30 | $25.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $48.83M derived: sum of 2 quarters · filed 2025-10-30 | $70.28M 10-Q · filed 2025-10-30 | $90.26M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $23.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $44.74M 10-Q · filed 2025-08-07 | $64.72M derived: sum of 3 quarters · filed 2026-02-19 | $84.71M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $21.45M 10-Q · filed 2025-05-08 | $41.43M derived: sum of 2 quarters · filed 2026-02-19 | $61.43M derived: sum of 3 quarters · filed 2026-02-19 | $79.78M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $19.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $39.98M derived: sum of 2 quarters · filed 2026-02-19 | $58.34M derived: sum of 3 quarters · filed 2026-02-19 | $74.78M 10-K · filed 2026-02-19 |
| 2023-09-30 | $19.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $38.35M derived: sum of 2 quarters · filed 2024-10-31 | $54.80M 10-Q · filed 2024-10-31 | $69.75M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $18.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $34.80M 10-Q · filed 2024-08-08 | $49.75M derived: sum of 3 quarters · filed 2025-02-20 | $65.41M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $16.44M 10-Q · filed 2024-05-09 | $31.39M derived: sum of 2 quarters · filed 2025-02-20 | $47.05M derived: sum of 3 quarters · filed 2025-02-20 | $61.31M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $14.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $30.60M derived: sum of 2 quarters · filed 2025-02-20 | $44.86M derived: sum of 3 quarters · filed 2025-02-20 | $57.69M 10-K · filed 2025-02-20 |
| 2022-09-30 | $15.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $29.91M derived: sum of 2 quarters · filed 2023-10-26 | $42.74M 10-Q · filed 2023-10-26 | $54.26M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $14.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $27.08M 10-Q · filed 2023-08-03 | $38.60M derived: sum of 3 quarters · filed 2024-02-22 | $50.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $12.82M 10-Q · filed 2023-05-04 | $24.34M derived: sum of 2 quarters · filed 2024-02-22 | $36.57M derived: sum of 3 quarters · filed 2024-02-22 | $48.31M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $23.75M derived: sum of 2 quarters · filed 2024-02-22 | $35.49M derived: sum of 3 quarters · filed 2024-02-22 | $46.02M 10-K · filed 2024-02-22 |
| 2021-09-30 | $12.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $23.97M derived: sum of 2 quarters · filed 2022-10-27 | $34.50M 10-Q · filed 2022-10-27 | $43.28M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $11.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $22.27M 10-Q · filed 2022-08-04 | $31.05M derived: sum of 3 quarters · filed 2023-02-23 | $39.96M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $10.54M 10-Q · filed 2022-05-05 | $19.31M derived: sum of 2 quarters · filed 2023-02-23 | $28.22M derived: sum of 3 quarters · filed 2023-02-23 | $37.69M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $17.69M derived: sum of 2 quarters · filed 2023-02-23 | $27.16M derived: sum of 3 quarters · filed 2023-02-23 | $36.16M 10-K · filed 2023-02-23 |
| 2020-09-30 | $8.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $18.38M derived: sum of 2 quarters · filed 2021-10-28 | $27.38M 10-Q · filed 2021-10-28 | $33.27M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $18.47M 10-Q · filed 2021-08-05 | $24.36M derived: sum of 3 quarters · filed 2022-02-17 | $31.15M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $9.00M 10-Q · filed 2021-05-06 | $14.89M derived: sum of 2 quarters · filed 2022-02-17 | $21.68M derived: sum of 3 quarters · filed 2022-02-17 | $29.04M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $12.68M derived: sum of 2 quarters · filed 2022-02-17 | $20.04M derived: sum of 3 quarters · filed 2022-02-17 | $26.97M 10-K · filed 2022-02-17 |
| 2019-09-30 | $6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $14.15M derived: sum of 2 quarters · filed 2020-10-29 | $21.08M 10-Q · filed 2020-10-29 | $27.12M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $7.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $14.29M 10-Q · filed 2020-08-06 | $20.32M derived: sum of 3 quarters · filed 2021-02-25 | $28.23M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $6.94M 10-Q · filed 2020-04-30 | $12.97M derived: sum of 2 quarters · filed 2021-02-25 | $20.87M derived: sum of 3 quarters · filed 2021-02-25 | $27.50M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $6.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $13.94M derived: sum of 2 quarters · filed 2021-02-25 | $20.57M derived: sum of 3 quarters · filed 2021-02-25 | $26.24M 10-K · filed 2021-02-25 |
| 2018-09-30 | $7.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $14.53M derived: sum of 2 quarters · filed 2019-10-30 | $20.20M 10-Q · filed 2019-10-30 | $24.95M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $6.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $12.30M 10-Q · filed 2019-08-01 | $17.04M derived: sum of 3 quarters · filed 2020-02-25 | $21.79M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $5.67M 10-Q · filed 2019-05-07 | $10.41M derived: sum of 2 quarters · filed 2020-02-25 | $15.16M derived: sum of 3 quarters · filed 2020-02-25 | $19.71M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $9.48M derived: sum of 2 quarters · filed 2020-02-25 | $14.04M derived: sum of 3 quarters · filed 2020-02-25 | $18.07M 10-K · filed 2020-02-25 |
| 2017-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $9.30M derived: sum of 2 quarters · filed 2018-10-30 | $13.33M 10-Q · filed 2018-10-30 | $17.49M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $8.59M 10-Q · filed 2018-08-02 | $12.75M derived: sum of 3 quarters · filed 2019-02-22 | $17.80M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $4.03M 10-Q · filed 2018-05-02 | $8.19M derived: sum of 2 quarters · filed 2019-02-22 | $13.24M derived: sum of 3 quarters · filed 2019-02-22 | $17.85M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $9.21M derived: sum of 2 quarters · filed 2019-02-22 | $13.82M derived: sum of 3 quarters · filed 2019-02-22 | $18.04M 10-K · filed 2019-02-22 |
| 2016-09-30 | $5.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $9.66M derived: sum of 2 quarters · filed 2017-11-02 | $13.88M 10-Q · filed 2017-11-02 | $17.71M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $8.83M 10-Q · filed 2017-08-03 | $12.67M derived: sum of 3 quarters · filed 2018-02-23 | $16.46M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $4.22M 10-Q · filed 2017-05-03 | $8.05M derived: sum of 2 quarters · filed 2018-02-23 | $11.85M derived: sum of 3 quarters · filed 2018-02-23 | $15.29M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $7.63M derived: sum of 2 quarters · filed 2018-02-23 | $11.07M derived: sum of 3 quarters · filed 2018-02-23 | $15.59M 10-K · filed 2018-02-23 |
| 2015-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $7.24M derived: sum of 2 quarters · filed 2016-11-03 | $11.76M 10-Q · filed 2016-11-03 | $14.49M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $7.96M 10-Q · filed 2016-08-04 | $10.70M derived: sum of 3 quarters · filed 2017-02-23 | $13.95M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $4.52M 10-Q · filed 2016-05-05 | $7.26M derived: sum of 2 quarters · filed 2017-02-23 | $10.51M derived: sum of 3 quarters · filed 2017-02-23 | $13.49M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $5.99M derived: sum of 2 quarters · filed 2017-02-23 | $8.97M derived: sum of 3 quarters · filed 2017-02-23 | $11.33M 10-K · filed 2017-02-23 |
| 2014-09-30 | $3.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $6.23M derived: sum of 2 quarters · filed 2015-11-06 | $8.59M 10-Q · filed 2015-11-06 | $10.85M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $5.34M 10-Q · filed 2015-08-06 | $7.59M derived: sum of 3 quarters · filed 2016-02-25 | $9.05M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $2.36M 10-Q · filed 2015-05-07 | $4.62M derived: sum of 2 quarters · filed 2016-02-25 | $6.07M derived: sum of 3 quarters · filed 2016-02-25 | $10.07M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.71M derived: sum of 2 quarters · filed 2016-02-25 | $7.71M derived: sum of 3 quarters · filed 2016-02-25 | $8.67M 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $5.46M derived: sum of 2 quarters · filed 2014-11-06 | $6.41M 10-Q · filed 2014-11-06 | $7.87M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $4.95M 10-Q · filed 2014-08-06 | $6.42M derived: sum of 3 quarters · filed 2015-02-27 | $6.92M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $954.00K 10-Q · filed 2014-05-08 | $2.42M derived: sum of 2 quarters · filed 2015-02-27 | $2.92M derived: sum of 3 quarters · filed 2015-02-27 | $3.44M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.97M derived: sum of 2 quarters · filed 2015-02-27 | $2.49M derived: sum of 3 quarters · filed 2015-02-27 | $2.98M 10-K · filed 2015-02-27 |
| 2012-09-30 | $505.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $1.02M derived: sum of 2 quarters · filed 2013-11-05 | $1.52M 10-Q · filed 2013-11-05 | $2.03M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-06-30 | $518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $1.01M 10-Q · filed 2013-08-06 | $1.52M derived: sum of 3 quarters · filed 2014-03-06 | $1.96M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-03-31 | $495.00K 10-Q · filed 2013-05-07 | $1.00M derived: sum of 2 quarters · filed 2014-03-06 | $1.44M derived: sum of 3 quarters · filed 2014-03-06 | $1.93M derived: sum of 4 quarters · filed 2014-03-06 |
| 2011-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $947.00K derived: sum of 2 quarters · filed 2014-03-06 | $1.43M derived: sum of 3 quarters · filed 2014-03-06 | $1.60M 10-K · filed 2014-03-06 |
| 2011-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $924.00K derived: sum of 2 quarters · filed 2012-11-07 | $1.09M 10-Q · filed 2012-11-07 | $1.24M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $652.00K 10-Q · filed 2012-08-07 | $803.00K derived: sum of 3 quarters · filed 2013-03-18 | $889.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $167.00K 10-Q · filed 2012-05-08 | $318.00K derived: sum of 2 quarters · filed 2013-03-18 | $404.00K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $237.00K derived: sum of 2 quarters · filed 2013-03-18 | $366.00K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $86.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | $215.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $129.00K 10-Q/A · filed 2011-08-08 | |||
| 2009-12-31 | $2.54M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |